People with diabetes, muscular degeneration, or Lou Gehrigs disease
GLP-1 mimics incretin, a gut hormone that aids in digestion and blood glucose control, essentially helping the body feel full
They are not intended for human consumption, clinical use, diagnostic use, therapeutic use, veterinary use, cosmetic use, or dietary supplement use
Novo Nordisk, behind Wegovy, is in the same race to innovate, with more user-friendly and effective versions of existing weight loss drugs
Suitable for any time of day and without special dietary considerations, it provides an average weight loss of 12.4% of body weight in clinical trials
Food stays in the stomach for a longer time and gives you a feeling of satiety, resulting in decreased appetite